Canada
· Delayed Price · Currency is CAD Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of CAD 293.40 billion. The enterprise value is 320.85 billion.
| Market Cap | 293.40B |
| Enterprise Value | 320.85B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.73% |
| Shares Change (QoQ) | -1.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.81B |
Valuation Ratios
The trailing PE ratio is 17.08.
| PE Ratio | 17.08 |
| Forward PE | n/a |
| PS Ratio | 3.94 |
| PB Ratio | 4.62 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.15, with an EV/FCF ratio of 13.72.
| EV / Earnings | 18.67 |
| EV / Sales | 4.10 |
| EV / EBITDA | 10.15 |
| EV / EBIT | 13.02 |
| EV / FCF | 13.72 |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.71.
| Current Ratio | 1.04 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 1.50 |
| Debt / FCF | 1.93 |
| Interest Coverage | 16.22 |
Financial Efficiency
Return on equity (ROE) is 26.28% and return on invested capital (ROIC) is 13.72%.
| Return on Equity (ROE) | 26.28% |
| Return on Assets (ROA) | 10.09% |
| Return on Invested Capital (ROIC) | 13.72% |
| Return on Capital Employed (ROCE) | 22.19% |
| Revenue Per Employee | 980,716 |
| Profits Per Employee | 226,417 |
| Employee Count | 75,883 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.54 |
| Average Volume (20 Days) | 555 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of CAD 74.42 billion and earned 17.18 billion in profits. Earnings per share was 8.45.
| Revenue | 74.42B |
| Gross Profit | 55.98B |
| Operating Income | 23.48B |
| Pretax Income | 19.63B |
| Net Income | 17.18B |
| EBITDA | 29.73B |
| EBIT | 23.48B |
| Earnings Per Share (EPS) | 8.45 |
Balance Sheet
The company has 19.21 billion in cash and 45.18 billion in debt, giving a net cash position of -25.97 billion.
| Cash & Cash Equivalents | 19.21B |
| Total Debt | 45.18B |
| Net Cash | -25.97B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 63.49B |
| Book Value Per Share | 32.09 |
| Working Capital | 1.46B |
Cash Flow
In the last 12 months, operating cash flow was 25.35 billion and capital expenditures -1.97 billion, giving a free cash flow of 23.39 billion.
| Operating Cash Flow | 25.35B |
| Capital Expenditures | -1.97B |
| Free Cash Flow | 23.39B |
| FCF Per Share | n/a |
Margins
Gross margin is 75.22%, with operating and profit margins of 31.55% and 23.09%.
| Gross Margin | 75.22% |
| Operating Margin | 31.55% |
| Pretax Margin | 26.37% |
| Profit Margin | 23.09% |
| EBITDA Margin | 39.95% |
| EBIT Margin | 31.55% |
| FCF Margin | 31.42% |
Dividends & Yields
Novartis AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 63.85% |
| Buyback Yield | 2.73% |
| Shareholder Yield | 2.73% |
| Earnings Yield | 5.86% |
| FCF Yield | 7.97% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novartis AG has an Altman Z-Score of 3.92.
| Altman Z-Score | 3.92 |
| Piotroski F-Score | n/a |